Affimed N.V. (AFMD), a German biotech company, announced on Wednesday a 1-for-10 reverse stock split of its outstanding common shares with a par value of 0.01 euro per share.
As a result of this announcement, the stock is experiencing a 19 percent decline in pre-market trading.
This move aims to meet the minimum $1.00 per share requirement set by Nasdaq listing rules.
The reverse stock split is scheduled to take effect on March 8, 2024, after the market closes.
The common shares are anticipated to commence trading on a post-split basis on March 11, 2024, under the same trading symbol.
In pre-market activity on the Nasdaq, the shares are trading at $0.55, down 19.28%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.